For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Injectables are a combination of dermal fillers and Botox used in facial aesthetic treatments, which help reduce wrinkles and play a crucial role in rejuvenating facial skin for smoother and younger look. These are injected under the skin or lips to plump up the tissues and gently lift it to restore collagen lost due to aging. Collagen and HA provide essential support to skin and help it retain its elasticity. The glabellar lines, wrinkles, and lines can be reduced with facial aesthetic treatment.
According to our (Global Info Research) latest study, the global Facial Injectables market size was valued at USD 9959 million in 2022 and is forecast to a readjusted size of USD 17580 million by 2029 with a CAGR of 8.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In terms of geographical regions, the Americas will be the major market contributor throughout the next few years. The US is the major revenue contributor in this region, where rapid advances in technology, the increasing awareness about aesthetic procedures, and the increasing demand for minimally invasive techniques, will bolster the market's growth prospects.
This report is a detailed and comprehensive analysis for global Facial Injectables market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Facial Injectables market size and forecasts, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2018-2029
Global Facial Injectables market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2018-2029
Global Facial Injectables market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2018-2029
Global Facial Injectables market shares of main players, shipments in revenue ($ Million), sales quantity (K Pcs), and ASP (USD/Pcs), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Facial Injectables
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Facial Injectables market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Allergan, Merz Aesthetics, Prollenium Medical Technologies, Bloomega BioTechnology and Galderma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Facial Injectables market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Botox
- Dermal Fillers
- Other
Market segment by Application
- Hospitals
- Clinics
- Cosmetic Centers
- Other
Major players covered
- Allergan
- Merz Aesthetics
- Prollenium Medical Technologies
- Bloomega BioTechnology
- Galderma
- Ipsen Group
- Suneva Medical
- Polymekon
- Visionmed
- Syneron
- Medytox
- AQTIS Medical
- ColBar LifeScience
- SciVision Biotech
- Hangzhou Techderm Biological Products
- Qufu Guanglong Biochem
Market segment by region, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Facial Injectables product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Facial Injectables, with price, sales, revenue and global market share of Facial Injectables from 2018 to 2023.
Chapter 3, the Facial Injectables competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Facial Injectables breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Facial Injectables market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Facial Injectables.
Chapter 14 and 15, to describe Facial Injectables sales channel, distributors, customers, research findings and conclusion.